hotspot -WSS

hotspot

author：leisure time 2025-09-27 23:00:51 - browse：396

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： New details revealed about Purdue's marketing of OxyContin

WSS

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Eye stem cell transplant could help restore vision in injured people

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Liz Cheney makes 1st public comment since Trump's election interference indictments

Patient advocates sound warning on FDA proposal on salt intake

hotspot

hotspot

knowledge

Psychedelics group wrestles with new pharma identity

Living with Hashimoto's and celiac disease, and med school, too

Hepatitis C has a cure — but many Americans still lack access to it

The best solution to the drug shortages problem

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Anavex keeps shifting the goalposts in its clinical trials

Jerome Adams on the need for new antivirals for Covid

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

How one medical school became remarkably diverse

In same hospitals, Black patients receive fewer opioids than white patients

knowledge

Wegovy trial has doctors encouraged over new possibilities

Methadone doses haven’t kept up in the age of fentanyl

Congress must give Medicare recipients genetic counseling access

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

What to know about Virgin Galactic's 1st mission taking paying customers to space

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

entertainment

knowledge

knowledge

explore